VASCULAR LEAKAGE, INFLAMMATION-PROVOKING, AND THROMBOTIC EVENTS IN CORONAVIRUS DISEASE 2019 view more CREDIT: NOVATEUR VENTURES A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled ‘A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes’ was published in Frontiers in Pharmacology, a...
by Harvard University Leaky lungs are a very common side effect of heart failure, but all currently available drugs do is reduce the amount of fluid in the body, rather than plug the leak itself. A new gene therapy created at the Wyss Institute and Boston Children’s Hospital and tested in human Lung Chips blocks...
Tom G. Bartol, MN, NP DISCLOSURES July 10, 2019 Loop diuretics are widely used in the management of edema and heart failure. They are also widely misunderstood. The reason is this: Loop diuretics are often prescribed in a dose-dependent strategy. Looking for gentle diuresis? Prescribe a low dose. For a more dramatic response, use a higher dose. But loop diuretics (eg, furosemide, torsemide, bumetanide) don’t work that way. Loop diuretics are “all-or-none” drugs; they...
Close monitoring appears to provide results equal to immediate treatment with lower cost and lower risk JOSLIN DIABETES CENTER BOSTON – (April 29, 2019) – A change to the approach for treating diabetic macular edema may be on the way, thanks to a study published today in the Journal of the American Medical Association. The...
